tiprankstipranks
Trending News
More News >
Recce Pharmaceuticals Ltd. (AU:RCE)
ASX:RCE
Australian Market
Advertisement

Recce Pharmaceuticals Ltd. (RCE) Income Statement

Compare
17 Followers

Recce Pharmaceuticals Ltd. Income Statement

Last quarter (Q4 2025), Recce Pharmaceuticals Ltd.'s total revenue was AU$562.52K, a decrease of -87.11% from the same quarter last year. In Q4, Recce Pharmaceuticals Ltd.'s net income was AU$-13.69M. See Recce Pharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
AU$ 7.51MAU$ 5.03MAU$ 4.37MAU$ 3.08MAU$ 1.64M
Gross Profit
AU$ -2.94MAU$ -2.19MAU$ 4.15MAU$ 2.90MAU$ 1.34M
Operating Expenses
AU$ 19.94MAU$ 21.68MAU$ 17.11MAU$ 13.96MAU$ 15.07M
Depreciation and Amortization
AU$ 71.85KAU$ 366.77KAU$ 217.16KAU$ 187.67KAU$ 295.63K
EBITDA
AU$ -20.33MAU$ -21.35MAU$ -16.99MAU$ -13.87MAU$ -14.77M
Operating Income
AU$ -22.88MAU$ -22.05MAU$ -17.33MAU$ -14.15MAU$ -15.36M
Other Income/Expenses
AU$ 1.45MAU$ -516.49KAU$ -63.06KAU$ 79.07KAU$ 285.08K
Pretax Income
AU$ -21.43MAU$ -22.57MAU$ -17.39MAU$ -14.07MAU$ -15.08M
Net Income
AU$ -21.43MAU$ -17.66MAU$ -13.08MAU$ -10.99MAU$ -13.51M
Per Share Metrics
Basic EPS
AU$ -0.09AU$ -0.10AU$ -0.07AU$ -0.06AU$ -0.09
Diluted EPS
AU$ -0.09AU$ -0.10AU$ -0.07AU$ -0.06AU$ -0.09
Weighted Average Shares Outstanding
236.98M 177.10M 175.71M 175.87M 156.95M
Weighted Average Shares Outstanding (Diluted)
236.98M 177.10M 175.71M 175.87M 156.95M
Currency in AUD

Recce Pharmaceuticals Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis